Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.

Stopped early · Early Phase 1

Conditions studied: Acne Vulgaris

In brief

To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 months in adult females treated with Next Science™ acne cream 2x or Next Science™ acne cream 1x in a double blind manner.

Key facts

Study ID

NCT03106766

Run by

Next Science TM

People needed

2

Starts

2017-03-27

Expected to finish

2017-08-14

Last updated by the study team

2017-08-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female ages 18 and above
• Has 20 or more inflammatory lesions on the face (papules and pustules) as determined by qualified examiner at Start of Treatment.
• In the area to be treated, has no significant facial dermatological conditions other than acne (as determined by the investigator) that would interfere with any study treatment or procedure
• Is willing and able to discontinue use of all baseline acne treatments for the duration of their trial participation
• Agrees to refrain from professional facial treatments during their trial participation.
• Agrees to avoid tanning booth use and minimize sun exposure during their trial participation.
• Is willing and able to follow instructions and procedures including attending scheduled study visits, which will require adequate transportation to the study site
• Is able to read, understand and sign the informed consent document and communicate with study staff and investigator.

You may not qualify if…

• Has more than 2 nodules/cystic acne lesions on the face
• Has a history of significant reactions to topical acne treatments, or a known allergy or hypersensitivity to any listed ingredients
• Has any history of skin malignancy
• Has used any systemic medications (including antibiotics, estrogens, retinoids) primarily for treatment of acne in the 21 days prior to randomization.
• Has used estrogens primarily as treatment for acne in the 21 days prior to randomization (estrogens prescribed for other reasons will be allowed if stable for at least 30 days prior to randomization).
• Has had any professional facial treatments in the 14 days prior to randomization.
• Has received any investigational treatment in the 30 days prior to randomization.
• Have any significant medical problems or other issues that would, in the investigator's judgment, affect their suitability for participation in this trial.

Where it is running

• Skin Laser & Surgery Specialists of NY & NJ — Hackensack, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.